Moreover, ErbB-2 is able to co-localize with the cyclin-dependent kinase p34Cdc2 in both the cytoplasm and the nucleus, and subsequently phosphorylate it, leading to resistance to taxol treatment in breast cancer [96], suggesting that ErbB-2 functions as a kinase in the nucleus. Here, ERBB2 is linked to breast cancer.